Perspective Study Based on Genetic Polymorphisms Related to Individual Variations of Side Effects of Cyclophosphamide in Systemic Lupus Erythematosus Treatment.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide (Primary)
- Indications Systemic lupus erythematosus
- Focus Pharmacogenomic; Therapeutic Use
- 08 Sep 2014 Biomarkers information updated
- 07 Oct 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Sep 2012 New trial record